期刊文献+

4-氨基哌啶类化合物的设计、合成及其对单胺递质再摄取的抑制活性

Design,synthesis and monoamine reuptake inhibitors activities of 4-aminopiperidine derivatives
原文传递
导出
摘要 目的设计合成4-氨基哌啶类化合物并研究其对中枢单胺递质(5-HT/NA/DA)的再摄取抑制活性。方法取代的4-氨基哌啶与氯代芳酮进行N-烷基化反应,经成盐制得目标产物Ⅰ1~Ⅰ9,再经硼氢化钠还原、成盐酸盐后制得目标产物Ⅰ10~Ⅰ17;经单胺递质再摄取抑制试验,对目标化合物的活性进行了初步测试。结果与结论共合成了17个未见文献报道的新化合物,经高分辨质谱及核磁共振氢谱确证结构。其中5个化合物对单胺递质再摄取具有一定的抑制活性。 Aim To design and synthesize 4-aminopiperidine derivatives monoamine reuptake inhibitors.Methods The target compounds Ⅰ1-Ⅰ9 were prepared by N-alkylation of 4-aminopiperidine derivatives,and compounds Ⅰ10-Ⅰ17 were obtained by reduction of compounds Ⅰ1-Ⅰ9 with NaBH4.Results and conclusion Seventeen new target compounds were synthesized and their structures were confirmed by HR-MS and 1H-NMR.The results of preliminary pharmacological test showed that five of seventeen compounds possessed diverse monoamine reuptake inhibitors activities.
出处 《中国药物化学杂志》 CAS CSCD 2010年第6期476-483,共8页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(30772623) 国家十一五"重大新药创制"项目(2009ZX09103-048)
关键词 4-氨基哌啶 单胺递质再摄取抑制剂 合成 4-aminopiperidine monoamine reuptake inhibitor synthesis
  • 相关文献

参考文献13

  • 1RICHELSON E. Pharmacology of antidepressants-char- acteristics of the ideal drug[ J]. Mayo Clin Proc,1994, 69(11):1069-1081.
  • 2HINDMARCH I. Expanding the horizons of depres- sion: beyond the monoamine hypothesis [ J ]. Hum Psychopharmacol Clin Exp,2001,16 ( 3 ) :203 - 218.
  • 3NEMEROFF C B ,THASE M E. A double-blind,pla- cebo-controlled comparison of venlafaxine and fluo- xetine treatment in depressed outpatients [ J ]. J Psy- chiatric Res,2005,9(4) :407 -416.
  • 4SKOLNICK P,POPIK P, JANOWSKY A, et al. "Broad spectrum" antidepressants :is more better for the treatment of depression? [ J ]. Life Sci, 2003,73 (35) :3175 -3179.
  • 5SKOLNICK P, POPIK P, JANOWSKY A, et al. An- tidepressant-like actions of DOV 21947: a "triple" reuptake inhibitor [ J ]. Eur J Pharmacol, 2003,461(2/3) :99 - 104.
  • 6BARBERICH T J. Sepracor presents at 22nd annual J P Morgan healthcare conference and highlights new clinical programs [ C ]. San Francisco: John Pierpont Morgan 22nd Ann Healthcare Conference ,2004.
  • 7LI J Q, HUANG L Y, DONG W X, et al. Aryl al- kanol piperazine derivatives and their uses as antide- pressants: US ,2005267121 A1 [ P]. 2005 - 12 - 01.
  • 8郑永勇,高凯,翁志洁,李建其.芳烷醇哌啶类化合物的合成及抗抑郁活性研究[J].药学学报,2010,45(3):324-329. 被引量:6
  • 9TEODORI E, BALDI E, DEI S, et al. Design, synthe- sis and preliminary pharmacological evaluation of 4- aminopiperidine derivatives as N-type calcium chan- nel blockers active on pain and neuropathic pain[ J]. J Med Chem,2004,47(24) :6070 -6081.
  • 10BROOKES P,TENY R,WALKER J. The chemo- therapy of filariasis. Analogues of diethylcarbamazine ( 1-diethylcarbamoyl-4-methylpiperazine ) derived from 2:4'-and 4:4'-dipiperidyl,homopiperazine, and 4-aminopiperidine[ J]. J Chem Soc, 1957,3165 - 3172.

二级参考文献13

  • 1WHO the world health report 2001, mental health: new understanding, new hope [EB/OL]. http://www.who.intJwhr/ 2001/en/.
  • 2World pharma sales 2001: US still driving growth [EB/OL]. http://www 1 .imshealth.com/web/content/0,3148,64576068 63872702_70260998_70328515,00. html.
  • 3Skolnick P, Popik P, Janowsky A, et al. "Broad spectrum" antidepressants: is more better for the treatment of depression? [J]. Life Sci, 2003, 73: 3175-3179.
  • 4Skolnick P, Popik P, Janowsky A, et al. Antidepressant-like actions of DOV 21947: a "triple" reuptake inhibitor [J]. Eur J Pharmacol, 2003, 461: 99-104.
  • 5Barberich TJ. Sepracor Presents at 22nd Annual JPMorgan Healthcare Conference and Highlights New Clinical Programs [C]. San Francisco: J.P. Morgan 22nd Ann Healthcare Conference, 2004.
  • 6Li JQ, Huang LY, Dong WX, et al. Aryl alkanol piperazine derivatives and their uses as antidepressants: US, 2005267121A1 [P]. 2005-12-01.
  • 7Petukhov PA, Zhang J, Kozikowski AP, et al. SAR studies of piperidine-based analogues of Cocaine. 4. Effect of N-modification and ester replacement [J]. J Med Chem, 2002, 45: 3161-3170.
  • 8Webb MB, Stack GP, Asselin M, et al. Antidepressant piperidine derivatives of heterocycle-fused benzodioxans: US, 6939877 [P], 2003-09-10.
  • 9E1 Ahmad Y, Fiez-Vandal PY, Laurent E, et al. N-(benzhydryloxyalkyl)-4-(carboxy/carbamoyl methyl)-piperidine derivatives as antidepressants: US, 5846980 [P]. 1998-12-08.
  • 10van Niel MB, Collins I, Beer MS, et al. Fluorination of 3-(3-(piperidin-l-yl) propyl)indoles and 3-(3-(piperazin-l-yl) propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles [J]. J Med Chem, 1999, 42: 2087-2104.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部